The invention concerns double-stranded HIF decoy oligodeoxynucleotide
(dsODN) molecules comprising a core sequence that is capable of specific
binding to a HIF transcription factor, compositions containing such
molecules, and their use in the treatment of various diseases and
pathologic conditions associated with the regulation of gene
transcription by a HIF transcription factor.